| The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma | |
| Zhao, Bei; Cheng, Xiankui; Zhou, Xiyuan | |
| 刊名 | MELANOMA RESEARCH
 |
| 2018 | |
| 卷号 | 28期号:6页码:521-526 |
| 关键词 | BET inhibitor BRAF inhibitor cancer drug resistance melanoma |
| DOI | 10.1097/CMR.0000000000000497 |
| URL标识 | 查看原文 |
| 公开日期 | [db:dc_date_available] |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/4583765 |
| 专题 | 山东大学 |
| 作者单位 | Sichuan Acad Med Sci, Inst Dermatol & Venereol, 32 Western 2nd Sect,1st Circle Rd, Chengdu 610072, Sichuan, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Zhao, Bei,Cheng, Xiankui,Zhou, Xiyuan. The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma[J]. MELANOMA RESEARCH,2018,28(6):521-526. |
| APA | Zhao, Bei,Cheng, Xiankui,&Zhou, Xiyuan.(2018).The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma.MELANOMA RESEARCH,28(6),521-526. |
| MLA | Zhao, Bei,et al."The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma".MELANOMA RESEARCH 28.6(2018):521-526. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论